SGN-LIV1A

Known as: Anti-LIV-1 Antibody-drug Conjugate SGN-LIV1A, Anti-LIV-1 Monoclonal Antibody-MMAE Conjugate SGN-LIV1A 
An antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against the anti-solute carrier family 39 zinc transporter… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

2008-2017
0120082017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Treatment choices for acute myelogenous leukemia (AML) patients resistant to conventional chemotherapies are limited and novel… (More)
Is this relevant?
2017
2017
Patients with relapsed/refractory B-cell malignancies such as non-Hodgkin lymphoma (B-NHL) or acute lymphoblastic leukemia have a… (More)
Is this relevant?
2016
2016
Intracochlear application of exogenous or transgenic neurotrophins, such as neurotrophin-3 (NT-3) and brain derived neurotrophic… (More)
Is this relevant?
Review
2015
Review
2015
Rituximab, a monoclonal antibody (MAb) against CD20, was the first MAb approved by the US Food and Drug Administration (FDA) for… (More)
Is this relevant?
2012
2012
Universal stress protein (USP) appears to play an active role in the abiotic stress response, but their functions remain largely… (More)
Is this relevant?
2010
2010
MicroRNA 159 (miR159) is a highly conserved miRNA with roles in flowering under short days, anther development and seed… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
Highly Cited
2008
Highly Cited
2008
The elucidation of gene expression patterns leads to a better understanding of biological processes. Real-time quantitative RT… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?